ZCMDNasdaqServices-Educational ServicesFiscal year ends December 31
Zhongchao Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 3, 2026
$1.38+0.07 (+5.34%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Zhongchao Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| MDMOOC Services [Member] | $10.68M | $13.71M | $10.41M | $12.94M | – | 93.9% | -22.1% |
| Sales of patented drugs [Member] | $696.44K | $2.15M | $9.03M | $1.22M | – | 6.1% | -67.6% |
| Total [Member] | – | – | – | $14.15M | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | YoY |
|---|---|---|---|---|---|---|
| Sales of patented drugs [Member] | $42.24K | $323.84K | $1.66M | $430.36K | – | -87.0% |
| MDMOOC Services [Member] | -$6.23M | -$665.11K | -$14.94M | -$3.38M | – | +837.2% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Service | $10.68M | $13.71M | $10.41M | $12.94M | $16.30M | 93.9% | -22.1% |
| Medical training and education services [Member] | $6.86M | $7.70M | $6.39M | $6.60M | $8.75M | 60.3% | -11.0% |
| Patient management services in patient-aid projects [Member] | $3.82M | $6.01M | $4.02M | $6.29M | $7.34M | 33.6% | -36.4% |
| Product | $696.44K | $2.15M | $9.03M | $1.22M | – | 6.1% | -67.6% |
| Sales of patented drugs [Member] | $696.44K | $2.15M | $9.03M | $1.22M | – | 6.1% | -67.6% |
| Other revenues [Member] | – | $97.78K | $22.54K | $42.33K | $199.31K | – | – |
By region
From the segment and revenue-disaggregation notes of Zhongchao's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.